logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

DfE claims primary success

14 December 2012

The Department for Education (DfE) is claiming that the new league tables vindicate its policy of challenging failing schools to improve or face forced academisation. With 60% less primary schools failing to hit floor targets, perhaps they have a point.

Understandably, teaching unions NAHT and the ATL disagree, taking the view that the tables show that schools can improve regardless of their status and that this is evidence that the current system is working well.

The sector is divided on the best approach, but it seems highly unlikely that Mr Gove will pull back from forced academisation or indeed slow the pace of change. Perhaps the government will go further and consider elements of the policy exchange report which suggests that the private sector could yet be a force for good in education.

Divided opinion will remain as will forced academisation. Perhaps Mr Gove may even up the pace of change in 2013.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up